Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd May 20, 2021
Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery Mechanisms May 20, 2021
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer May 20, 2021
MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children’s Hospital, as Company… May 19, 2021
More Than 80% Of Americans Report One Or More Symptoms Of Depression, And Many Have Turned To Substances To Cope With… May 18, 2021